Sarasota's Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimer's Diseas... (ients is receiving positive safetyreview...)

Sarasota's Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimer's Disease Research

Date:12/14/2007

ients is receiving positive safety reviews.

While the drug, Amlodipine, is one of the top drugs sold in the United States for the treatment of hypertension (high blood pressure), Nilvadipine, is currently not available in the U.S. However, the Roskamp Institute plans to introduce Nilvadipine to the U.S. Food and Drug Administration as a part of its phase II study early next year.

"As the authors of the Japan study propose, our Institute's researchers are planning to investigate whether the Japan study finding can be replicated in a larger participant study," said Dr. Fiona Crawford, associate director of the Roskamp Institute, who has been working alongside Dr. Mullan in researching Nilvadipine for its use in Alzheimer's disease. "As we continue to move forward in our studies, we are hopeful that we are well on our way to finding a drug that will be useful in slowing down or preventing this devastating disease."

In addition, the Roskamp Institute is looking for volunteers who have been diagnosed with Alzheimer's disease or Multiple Sclerosis to participate in Roskamp's ongoing research studies. If you or someone you know is interested in participating, please contact our Clinical Trials Division at (941) 256- 8018.

The Roskamp Institute is a not-for-profit research Institute located in Sarasota and Tampa, Florida, that is dedicated to understanding the causes of, and finding cures for, neuropsychiatric and neurodegenerative disorders and addictions with an emphasis on Alzheimer's disease. The Institute's Memory Clinics also offer comprehensive cognitive and medical assessment toward differential diagnosis of Alzheimer's disease and offers treatments and disease management options once the diagnostic evaluation is complete.

For more information, please contact the Roskamp Institute in Sarasota at (941) 752-2949, the Roskamp Institute Clinical Trials Division in Sarasota at (941) 256-8018 the Roskamp Institute Memory Center in Tampa
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. Sports Legacy Institute Announces Findings of Forensic Examinations on Wrestler Chris Benoits Brain
3. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
4. Spine Institute of Louisiana Offers Cervical Spine Motion Preservation as an Alternative to Fusion Surgery
5. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
6. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
7. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
8. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
9. American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. American Legion Anticipates Institute of Medicine Report on Gulf War Veterans

Post Your Comments:

Sarasota's Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimer's Diseas...(ients is receiving positive safetyreview...),Health